Venus Concept

Venus Concept, Inc. develops, commercializes and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related practice enhancement services. Its product portfolio consists of aesthetic device platforms which includes venus versa, venus legacy, venus velocity, venus fiore, venus viva, venus freeze plus, and venus bliss. The company was founded on November 22, 2002 and is headquartered in Toronto, Canada.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Venus Concept surpasses revenue expectations in Q1 2024 earnings call

Venus Concept's Q1 2024 performance showed resilience with revenue exceeding expectations despite challenges. Strategic initiatives to exit unprofitable markets and focus on cash system sales led to improved financial metrics. The company's progress in key initiatives and financial improvements demonstrate a commitment to long-term growth and stability.

Venus Concept reports mixed Q3 results, eyes growth opportunities

Venus Concept faced revenue challenges in Q3 2024, but saw growth in distributor sales and progress in restructuring efforts. Despite financial setbacks, the company is optimistic about new product launches, regulatory clearances, and debt reduction strategies. Analyst interest remains high in revenue mix, new product launches, market strengths, and debt management.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Venus Concept, Inc. is a global medical technology company, which engages in the business of developing, commercializing, and selling minimally invasive and non-invasive medical aesthetic and hair restoration technologies. It operates under the United States and International geographical segments. The company was founded on November 22, 2002 and is headquartered in Toronto, Canada.

TORONTO, May 15, 2023 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three months ended March 31, 2023.

Venus Concept Announces First Quarter of Fiscal Year 2023 Financial Results

TORONTO, May 15, 2023 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has entered into a stock purchase agreement (the “Stock Purchase Agreement”) with funds affiliated with EW Healthcare Partners (the “Investors”). Pursuant to the Stock Purchase Agreement, the Company may issue and sell to the Investors up to $9,000,000, before offering expenses, in shares of senior convertible preferred stock (the “Senior Preferred Stock”), in multiple tranches from time to time until December 31, 2025. Offering proceeds will be used for working capital and general corporate purposes.

Venus Concept Inc. Announces Multi-Tranche Private Placement of Senior Convertible Preferred Stock for up to $9 Million with EW Healthcare Partners

TORONTO, May 11, 2023 (GLOBE NEWSWIRE) --  Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that its Board of Directors approved a 1-for-15 reverse stock split of the Company's issued and outstanding common stock (the “Reverse Stock Split”). The Reverse Stock Split will be effective at 5:00 p.m. Eastern Daylight Time today. The Company's common stock is expected to begin trading on The Nasdaq Capital Market on a split-adjusted basis at the open of trading on May 12, 2023.

Venus Concept Announces 1-for-15 Reverse Stock Split

TORONTO, April 11, 2023 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that first quarter of fiscal year 2023 financial results will be released before the market opens on Monday, May 15, 2023.

Venus Concept to Release First Quarter of Fiscal Year 2023 Financial Results on May 15, 2023

Venus Concept Inc. (NASDAQ:VERO ) Q4 2022 Earnings Conference Call March 27, 2023 8:00 AM ET Company Participants Rajiv De Silva - Chief Executive Officer Hemanth Varghese - President and Chief Innovation and Business Officer Domenic Della Penna - Chief Financial Officer Conference Call Participants Marie Thibault - BTIG Anthony Vendetti - Maxim Group Jeffrey Cohen - Ladenburg Thalmann Operator Good day ladies and gentlemen and welcome to the Fourth Quarter 2022 Earnings Conference Call for Venus Concept Inc. At this time, all participants have been placed in a listen-only mode. Please note that this conference call is being recorded and that the recording will be available on the company's website for replay.

Venus Concept Inc. (VERO) Q4 2022 Earnings Call Transcript

TORONTO, March 27, 2023 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three and twelve months ended December 31, 2022.

Venus Concept Announces Fourth Quarter and Fiscal Year 2022 Financial Results; Introduces Fiscal Year 2023 Revenue Guidance

TORONTO, March 20, 2023 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, announced today the launch of its latest generation of ARTAS iX, which is now broadly available to physicians specializing in hair transplantation worldwide.

Venus Concept Announces the Launch of its latest generation of ARTAS iX, the World's Most Advanced Robotic Hair Restoration System

TORONTO, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that fourth quarter and fiscal year 2022 financial results will be released before the market opens on Monday, March 27, 2023.

Venus Concept to Release Fourth Quarter and Fiscal Year 2022 Financial Results on March 27, 2023

Restructuring plan includes cost reduction programs to right-size operating structure while prioritizing investments on strategic growth initiatives Restructuring plan includes cost reduction programs to right-size operating structure while prioritizing investments on strategic growth initiatives

Venus Concept Announces Strategic Business Realignment to Accelerate Its Path to Long-Term, Sustainable, Profitability and Reports Preliminary Revenue Results for Fourth Quarter and Fiscal Year 2022

Avaya Holdings

Cenntro Inc

Laser Photonics Corp

Can this help you to make money with penny stocks? The post Trading Penny Stocks?

Trading Penny Stocks? Top Technical Analysis Tips

Venus Concept (NASDAQ: VERO ) stock is rocketing higher on Wednesday following approval for its fractional skin resurfacing technology. The U.S. Food and Drug Administration (FDA) has signed off on the company's surgical robotic technology platform called AI.ME.

Why Is Venus Concept (VERO) Stock Up 81% Today?

Venus Concept Inc has received an FDA 510(k) clearance to market its AI.ME next-generation robotic technology for fractional skin resurfacing.

Why Venus Concept (VERO) Shares Are Trading Higher Premarket Today?

Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has received a 510(k) clearance from the U.S. Food and Drug Administration (“FDA”) to market its AI.ME next generation robotic technology for fractional skin resurfacing.

Venus Concept Receives 510(k) Clearance for Use of its AI.ME™ Next Generation Robotic Technology for Fractional Skin Resurfacing

Babcock & Wilcox Enterprises

Muscle Maker

NRX Pharmaceuticals

Tenaya Therapeutic

Vapotherm Inc

Insiders and hedge funds are buying these penny stocks before December 2022. The post Penny Stocks To Buy: 6 Insider Picks Before December 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Penny Stocks To Buy: 6 Insider Picks Before December 2022

Insiders and hedge funds are buying these penny stocks in November. The post Penny Stocks To Buy: Insiders & Hedge Funds Like These 3 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Penny Stocks To Buy: Insiders & Hedge Funds Like These 3

Charah Solutions Inc

Canoo

Heliogen

Porch Group

Satsuma Pharmaceuticals Inc

TFF Pharmaceuticals

7 penny stock picks from insiders in November 2022 The post Best Penny Stocks To Buy Now? 7 Insider Picks In November appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Best Penny Stocks To Buy Now? 7 Insider Picks In November

Penny stock picks from insiders in November 2022. The post Best Penny Stocks To Buy Now?

Best Penny Stocks To Buy Now? 4 Insider Picks In November

Fintel reports that Masters Capital Management Llc has filed a 13D/A form with the SEC disclosing ownership of 22,999,173 shares of Venus Concept Inc (VERO).

Activist Masters Capital Double Position in Venus Concept (VERO)

TORONTO, Nov. 18, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has completed a non-brokered private placement (the “Private Placement”) of convertible preferred stock (the “Preferred Shares”) and common stock (the “Common Shares”) of the Company. Pursuant to the Private Placement, an aggregate of 3,185,000 Preferred Shares and 1,750,000 Common Shares were issued, resulting in aggregate gross proceeds to the Company of $6.72 million before offering expenses, which will be used for working capital and general corporate purposes.

Venus Concept Announces Completion of $6.72 Million Private Placement Financing

Venus Concept Inc. (NASDAQ:VERO ) Q3 2022 Earnings Conference Call November 10, 2022 5:00 PM ET Corporate Participants Rajiv De Silva - Chief Executive Officer Domenic Della Penna - Chief Financial Officer Conference Call Participants Jeff Cohen - Ladenburg Thalmann Marie Thibault - BTIG Anthony Vendetti - Maxim Group Operator Good day, ladies and gentlemen and welcome to the Third Quarter 2022 Earnings Conference Call for Venus Concept Inc. At this time, all participants have been placed in a listen-only mode. Please note that this conference call is being recorded and that the recording will be available on the company's website for replay.

Venus Concept Inc. (VERO) Q3 2022 Earnings Call Transcript

TORONTO, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three and nine months ended September 30, 2022.

Venus Concept Announces Third Quarter of Fiscal Year 2022 Financial Results

TORONTO, Oct. 19, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has issued a stock option inducement grant to its President and Chief Business Officer, Hemanth Varghese, upon the effective date of his employment agreement on October 17, 2022. The inducement grant was approved by a majority of the Company's independent directors in accordance with Nasdaq Listing Rule 5635(c)(4), which also requires a public announcement.

Venus Concept Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

TORONTO, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced the appointment of Dr. Hemanth Varghese to the position of President & Chief Business Officer, effective October 17, 2022.

Venus Concept Appoints Dr. Hemanth Varghese as President & Chief Business Officer

TORONTO, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that it is updating the release date for its third quarter of fiscal year 2022 financial results. Third quarter financial results will now be released after the market closes on Thursday, November 10, 2022.

Venus Concept Announces Updated Release Date of November 10, 2022 for Third Quarter of Fiscal Year 2022 Financial Results

TORONTO, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that Rajiv De Silva has been appointed as the Company's Chief Executive Officer and a member of the Board of Directors (the “Board”), effective October 2, 2022. The Company also announced the separation of Domenic Serafino as Chief Executive Officer and Director, effective October 2, 2022. This separation was not the result of any specific disagreement about strategy with management or the Board, inappropriate action, violation of company policy or any accounting irregularity.

News for Venus Concept Stock (VERO)